CBLL (CeriBell, Inc.) Stock Financials & Earnings

CBLLCeriBell, Inc.

Mkt Cap$704M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$89M

Net Income (TTM)-$53M

EPS (TTM)-$1.47

Free Cash Flow (TTM)-$42M

Gross Margin87.9%

Op. Margin-65.6%

Net Margin-60.0%

FCF Margin-47.0%

P/S Ratio (TTM)7.9x

P/E Ratio (TTM)—

YoY Rev Growth+36.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$10M	$9M	-$7M
Q2 23	$10M	$9M	-$7M
Q3 23	$12M	$10M	-$7M
Q4 23	$13M	$11M	-$8M
Q1 24	$15M	$13M	-$8M
Q2 24	$15M	$13M	-$8M
Q3 24	$17M	$15M	-$10M
Q4 24	$19M	$16M	-$13M
Q1 25	$20M	$18M	-$14M
Q2 25	$21M	$19M	-$15M
Q3 25	$23M	$20M	-$15M
Q4 25	$25M	$22M	-$15M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$2M	$5M	$9M
Q2 23	$2M	$5M	$9M
Q3 23	$2M	$5M	$10M
Q4 23	$3M	$6M	$11M
Q1 24	$3M	$7M	$11M
Q2 24	$3M	$7M	$11M
Q3 24	$3M	$9M	$13M
Q4 24	$4M	$10M	$15M
Q1 25	$4M	$10M	$18M
Q2 25	$5M	$11M	$17M
Q3 25	$5M	$11M	$19M
Q4 25	$5M	$12M	$19M

Revenue Segments

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$34M	$0	$34M
Q1 24	$0	$0	$0
Q2 24	$24M	$0	$24M
Q3 24	$14M	$0	$14M
Q4 24	$194M	$0	$194M
Q1 25	$153M	$29M	$183M
Q2 25	$40M	$137M	$177M
Q3 25	$24M	$145M	$169M
Q4 25	$40M	$119M	$159M

Shares Outstanding

Revenue Per Employee

Revenue / Employee